key: cord-0327571-t4vg0ovg authors: Wagner, R.; Heni, M.; Tabak, A. G.; Machann, J.; Schick, F.; Randrianarisoa, E.; Hrabe de Angelis, M.; Birkenfeld, A.; Stefan, N.; Peter, A.; Häring, H.-U.; Fritsche, A. title: Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes date: 2020-10-14 journal: nan DOI: 10.1101/2020.10.12.20210062 sha: a5d88a0beaa72ceba91702e2fdde84ab8fb6d5d6 doc_id: 327571 cord_uid: t4vg0ovg The state of intermediate hyperglycemia is indicative of elevated risk of developing type 2 diabetes. However, the current definition of prediabetes neither reflects subphenotypes of pathophysiology of type 2 diabetes nor is it predictive of future metabolic trajectories. We used partitioning on variables derived from oral glucose tolerance tests, MRI measured body fat distribution, liver fat content, and genetic risk in a cohort of extensively phenotyped individuals who are at increased risk for type 2 diabetes to identify six distinct clusters of subphenotypes. Three of the identified subphenotypes have increased glycemia (clusters 3, 5 and 6), but only individuals in clusters 5 and 3 have immanent diabetes risks. By contrast, those in cluster 6 have moderate risk of type 2 diabetes, but an increased risk of kidney disease and all-cause mortality. Findings were replicated in an independent cohort using simple anthropomorphic and glycemic constructs. This proof-of-concept study demonstrates that pathophysiological heterogeneity exists before diagnosis of type 2 diabetes and highlights a group of individuals who have an increased risk of complications without rapid progression to overt type 2 diabetes. Type 2 diabetes occurs when insulin secretion from pancreatic beta-cells cannot sufficiently be increased to compensate for insulin resistance. Causes of beta-cell dysfunction and insulin resistance are heterogeneous, as are individual trajectories of hyperglycemia and subsequent manifestation of diabetes complications 5 . The currently used binary definition of type 2 diabetes is based solely on blood glucose and cannot differentiate between patients with mild or more aggressive disease, the latter of which is prone to early development of complications. In addition to blood glucose, new proposed diabetes classifications 6,7 introduced additional variables, such as insulin secretion and insulin sensitivity, to sub-classify the type 2 diabetes spectrum with the primary aim of a better prediction of metabolic dysfunction and complications. The development of type 2 diabetes is a slow process, and its manifestation is preceded by a phase of prediabetes which often remains undiagnosed. Some diabetes complications, such as the unexpectedly frequent early diabetic kidney disease in the newly identified severe insulin resistant diabetes cluster 6 , might require preventive actions prior to the clinical manifestation of type 2 diabetes. The assessment of insulin secretion and insulin sensitivity could be hindered by secondary gluco-lipotoxicity, once diabetes has developed and glucose levels are continuously elevated 8 . Determination of prediabetes subphenotypes prior to the manifestation of diabetes could improve detection of individuals at risk for diabetes and complications. Using accurate measurements of insulin sensitivity and insulin secretion based on oral glucose tolerance test (OGTT)-derived variables, as well as variables linked to diabetes pathogenesis, we describe a novel subphenotyping approach of metabolic risk before diabetes manifestation. Variables include HDL-cholesterol, which has been causally linked to type 2 diabetes 9 , MR-imaging-derived measures of metabolically unfavorable and favorable fat compartments 10 and liver fat content measured with 1 H-MR-spectroscopy. To assess genetic liability, we also incorporated a type 2 diabetes polygenic risk score 11 as partitioning variable. The clusters identified by the sophisticated phenotypes in the TUEF/TULIP cohort were replicated using simpler markers of similar anthropometric and glycemic constructs in a large prospective occupational cohort (the Whitehall II study) 4 . Our results suggest that stratification of 5 Initial clustering and identification of the subphenotypes was done using data from a subset of participants (n=899) from the Tuebingen Family study and Tuebingen Lifestyle Program (TUEF/TULIP) study. Analysis was performed on data for participants who had no missing values for the preselected phenotyping variables: glucose challenge; insulin sensitivity; insulin secretion; HDL-cholesterol; liver fat content; subcutaneous fat volume; visceral fat volume; and a polygenic risk score for type 2 diabetes risk The clustering was replicated in the Whitehall II cohort (n=6810) using conceptually similar variables: glycemia during glucose challenge, insulin sensitivity, insulin secretion, fasting insulin, fasting triglycerides, waist circumference, hip circumference, BMI and HDL-cholesterol (Extended Data 1; see Methods). We identified six clusters with distinctive patterns of the variables in the TUEF/TULIP study ( Figure 1 .A,B), which were replicated in the Whitehall II cohort (Figure 1 C,D). Cluster characteristics and comparisons are shown in Table 1 , Suppl. Table 1-3 and key features of the clusters are reported in Extended Data 2. There was a cluster-specific enrichment of the diabetes-related genetic variant rs10830963 in MTNR1B (ANOVA p=0.02 after Benjamini-Hochberg correction for multiple testing, Suppl. Table 4 ). Participants in cluster 3 had higher frequency of the diabetes-associated G allele compared with those in cluster 1 (uncorrected p=0.00036 for cluster 3 relative to cluster 1). Using the pathophysiological classification of diabetes-related genetic variants proposed by Udler et al 12 , we found differences within the beta-cell group (uncorrected p=0.001, p=0.007 after Benjamini-Hochberg correction, Figure 2 .A). Pairwise comparisons showed significant differences between cluster 6 and each of clusters 1, 2 and 3 (ANOVA with Tukey's post-hoc test p<0.05), suggesting a lower abundance of betacell function related risk alleles in cluster 6. In the longitudinal analysis, all participants with available data were followed for the development of diabetes, nephropathy, cardiovascular endpoints and all-cause mortality ( Figure 3 ). The proportional hazards assessment in Whitehall II is shown in 6 Suppl. Table 5 . Diabetes incidence was the highest in cluster 5, followed by cluster 3 in both the TUEF/TULIP and Whitehall-II cohorts. Mean follow-up was 4.1 and 16.3 years, respectively. In TUEF/TULIP, participants in cluster 6 did not demonstrate an increased risk for diabetes ( Figure 3 .A). The diabetes-risk of cluster 6 was only moderately elevated in Whitehall II (HR 2.22[CI:1.7-2.89] compared with cluster 1. respectively, compared with cluster 1, (Figure 3 .C, Suppl. Table 5 ). By contrast, cluster 2 had a significantly lower risk of developing diabetes in the Whitehall II cohort compared with cluster 1 (HR 0.4[CI:0.33-0.47]). Current smoking was a risk factor for diabetes in Whitehall II, but did not affect the risk of diabetes for participants in clusters 3, 5 and 6 (Suppl. We used two approaches to compare our multivariable clustering with glucose-based stratification alone. We first tested cumulative diabetes risk for the Hulman classes 13 that are computed from the glucose course during an OGTT (Extended Data 4). Next, we stratified the baseline AUC glucose of Whitehall II into 5 quintiles, (Extended Data 5). In head-to-head comparisons, the cumulative diabetes risk of the high risk clusters 3 and 5 together was higher than that of Hulman-classes 3 and 4 together (p=0.04, TUEF/TULIP) and also higher than that of the top 2 AUC glucose quintiles (p<0.0001, Whitehall II, both log-rank tests). Thus, our cluster-based approach was superior to both of these approaches in delineating groups with high cumulative risk for development of diabetes. The overall difference in the Kaplan-Meier curves for microalbuminuria did not reach statistical significance in TUEF/TULIP (mean follow-up 4.3 years, number of events=71, plog-rank, uncorrected=0.061, Figure 3 .B). In the proportional hazard assessment, cluster 6 showed a significantly higher risk for microalbuminuria compared with cluster 1 (p=0.01). Results were similar but not significant for the Whitehall II participants with available baseline urine measurements (n=316, number of events=58, uncorrected p=0.058) when adjusting for baseline urinary albumin-to-creatinine ratio. In Whitehall II, participants in cluster 6 had a significantly higher risk for stage 3 chronic kidney disease or worse than cluster 1 (uncorrected p=0.0003, mean follow-up 18.2 years, number of events 1387, Figure 3 .D, Extended Data 6). Individuals in the diabetes susceptible clusters 3 and 5 also demonstrated higher risks for chronic kidney disease relative to cluster 1 in Whitehall II (uncorrected p=0.004 and p=0.02, respectively, Suppl. Table 5 ). The fully adjusted model also controlled for smoking, cholesterol and triglycerides is shown in Suppl. Table 8 . Given that participants in cluster 6 had elevated visceral fat, we hypothesized that this could be associated with fat in the renal sinuses, which is a risk factor for exercise-induced microalbuminuria 14 . TUEF/TULIP participants in cluster 6 had the most renal sinus fat compared with other clusters (p<0.05 for all pairwise comparisons, Tukey's post-hoc test, Figure 2 .B, N=199). It was higher than in cluster 5 after adjusting for potential confounders (Suppl .Table 9 .A-D). In the TUEF/TULIP cohort, we used carotid intima media thickness (IMT) as a proxy for cardiovascular end-points due to a lack of a register-based assessment of clinical events. IMT was associated with cluster membership (F=14.55, degrees of freedom=5, p<0.001). Each of clusters 3, 5 and 6 had higher IMT values than each of clusters 1, 2 or 4 (Extended Data 7 and Suppl. Table 1 , p<0.002). After adjustment for sex, age, age² and BMI, cluster 3 and 5 had higher IMT than cluster 1 (p<0.03). In the Whitehall II cohort, we evaluated the incidence of coronary heart disease (CHD, mean follow-up 17.2 years, 800 events, see Figure 2 .E). As a combined vascular endpoint, we also investigated the incidence of CHD and stroke (mean follow-up 22.9 years, 1040 events, Suppl. Table 5 ). In the proportional hazard assessment, the elevated cardiovascular risk in cluster 5 was not independent from sex, age and BMI, but . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint 8 consistently lower in cluster 2 compared with cluster 1, also after adjustments (Suppl .Table 5 ). Compared with cluster 1 in Whitehall II, all-cause mortality was by about 40% higher for cluster 6 ( Figure 3 .F), while cluster 2 had a lower mortality rate, even after adjustments for covariates (Suppl. Table 5 ). The elevated mortality risk in cluster 6 (relative to cluster 1) was not affected by adjustment for smoking and lipids (full model in Suppl. Table 10) . . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint 9 The applied variable-based partitioning of individuals without type 2 diabetes yielded groups differing in risk for type 2 diabetes and its complications. We validated these findings using simple measures of the same pathophysiological constructs in a large occupational cohort. Cluster 5 was identified as the subpopulation of the highest risk of type 2 diabetes, renal and vascular disease and all-cause mortality. Individuals in this cluster had obesity, insulin resistance, high levels of fatty liver and low insulin secretion. Cluster 6 represented an insulin resistant phenotype, in which participants had high amounts of visceral fat, but less liver fat and higher insulin secretion compared with cluster 5. About half of the participants in cluster 6 had prediabetes on enrollment in the TUEF/TULIP study. However, mean glycemia (AUC glucose) was lower than in cluster 5, and the risk of type 2 diabetes was considered to be moderate. Nonetheless, participants in cluster 6 had high risk for microalbuminuria and chronic kidney disease. Cardiovascular risk was not elevated in this cluster; however, overall mortality was about 40% higher than in the reference cluster 1 even after adjustment for confounders. Thus, clusters 5 and 6 both constitute obese, high-risk subpopulations with different glycemic, renal, cardiovascular and all-cause mortality risk profiles. Glucose does not seem to be the major driver of clinical events in cluster 6. Previous observations of an association of insulin resistance with diabetic nephropathy 15-17 highlight insulin resistance as a probable underlying factor. The discrepancy between moderate type 2 diabetes and high nephropathy risk for cluster 6 is not dependent from baseline blood pressure. However, individuals in cluster 6 had elevated renal sinus fat, which could contribute to manifestation of nephropathy. We previously showed an association between renal sinus fat and exercise-induced albuminuria in a cross- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint renal sinus fat in cluster 6. Cluster 6, in which participants had moderate or delayed risk of diabetes, showed a relatively low genetic risk for type 2 diabetes and a low abundance of genetic variants from the beta-cell class in the Udler classification 12 . This result implies an effective compensation of insulin resistance through excellent beta-cell function. We speculate that hyperinsulinemia associated with the combination of good beta-cell function and insulin resistance contributes to renal disease and mortality 19-21 . Smoking was a risk factor both for diabetes and chronic kidney disease 22-24 , but did not explain the differences among clusters. Contrast to the three high-risk clusters 3, 5 and 6, cluster 4 comprises participants with obesity but low glycemic deterioration. Phenotypic traits of individuals in this cluster are compatible with the concept of metabolically healthy obesity 25 . Cluster 4 was also associated with lower risk of type 2 diabetes, independently from sex, age, and BMI. Individuals in this cluster had body fat predominantly stored in subcutaneous rather than visceral depots, a pattern known to be metabolically more favorable 26 . In cluster 3, the partitioning identified a phenotype characterized by elevated genetic risk and low insulin secretion, which might explain the high diabetes incidence seen in this group. The moderately elevated visceral fat compartment correlates with pancreatic fat, which has been associated with disturbed insulin secretion in a prediabetic environment 18,27,28 . Cluster 3 with a disposition index as low as cluster 5, but higher insulin sensitivity could correspond to beta-cell dysfunction subphenotypes identified in previous studies 6,7,29 . Cluster 3 had high IMT, independent from sex, age and BMI. Increased cardiovascular risk was not replicated for this cluster in Whitehall II, but individuals in this cluster had a moderately elevated risk of chronic kidney disease. Our clustering approach is not designed to provide definitive subphenotypes for individual patients in a clinical setting; however, the approach can be helpful for is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . from a standard aerobic exercise and dietary caloric restriction via reduction of visceral fat. Although clusters 3 and 5 have elevated genetic risk as non-modifiable risk factor, genetic predisposition might be protective against development of type 2 diabetes for individuals with a cluster 6 phenotype. This group could be easily overlooked when risk-stratification focuses on established diabetes-related glycemic cut-offs. Insulin resistance with or without prevalent prediabetes associates with renal disease and elevated mortality in cluster 6, which should motivate consideration of preventive measures even with low glycemic progression. Our subphenotyping was performed in persons who did not yet suffer from diabetes, but who are at potentially increased risk, as demonstrated by the newly diagnosed cases in the follow-up period. The classification emerges partly from variables that require an OGTT. OGTT-derived glycemic traits can reasonably assess insulin sensitivity and secretion, particularly in the absence of diabetes. An elegant metabolic clustering of glycemic courses during OGTT has been proposed by Hulman et al 13 . We have applied an alternative approach with a broad set of variables in addition to OGTT. Our data complement other clustering approaches targeting the disentanglement of the heterogeneity of adult-onset diabetes 6,7,12 . We show that cluster 6 most strongly connects to the SIRD cluster of the Ahlqvist-classification 6,30 . Cluster 6 and SIRD bear similarities, such as an elevated risk of nephropathy in the absence of marked glucose elevation. Thus, accumulating data indicate that the pathogenesis of kidney damage in type 2 diabetes appears to be different from that of type 1 diabetes, with only a minor contribution of glycaemia in prediabetes and type 2 diabetes. Of note, by contrast with the Ahlqvist-classification, our work analyzed screen-detected diabetes cases as outcomes during the follow-up periods. These cases probably have milder phenotypes than clinically detected type 2 diabetes cases. Our results are demonstrated in two independent study groups: a cohort by design enriched in diabetes-prone persons and a UK occupational cohort. This most likely contributes to the observed differences between the Kaplan-Meier plots in the two cohorts, especially for diabetes incidence. Given the lack of ethnic diversity of the investigated populations leveraged in our study, our findings might only be applicable to white European populations. We also acknowledge the limitations of the partitioning approach: there is uncertainty with regard to variable selection, the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . 12 optimal number of clusters and whether these approaches are inferior to conventional predictions from multivariable modeling 29 . Additional specific limitations of our work are the different feature variable set and the moderate reassignment rate (63%) of the original clusters to the feature set of Whitehall II. Given the sophisticated nature of the variables in TUEF/TULIP cohort, the clinical utility of these features for metabolic classification could be limited. Further, in the TUEF/TULIP cohort, only about half of the population was available for follow-up visits. This high attrition rate could lead to a potential underestimation of the risk for diabetes and nephropathy in the TUEF/TULIP cohort. A final limitation is that the nephropathy models in Whitehall II are not adjusted for baseline eGFR due to a lack of baseline measurements and the absolute risks being low. In summary, we show the feasibility of multi-variable subphenotyping in individuals without diabetes to disentangle metabolic heterogeneity prior to diagnosis of type 2 diabetes. The metabolic clusters identified here associate with future complications related to prediabetes, insulin resistance, future risk of type 2 diabetes and mortality. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint We thank all the research volunteers for their participation. We thank all participants in the Whitehall II Study, Whitehall II researchers and support staff who made the study possible. We gratefully acknowledge the excellent technical assistance of the We declare that none of the authors have competing financial or non-financial interests as defined by Nature Research is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint Panel a, b) and 9 variables in the Whitehall-II cohort (N=6810, Panel c, d) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . Table 1 Cluster characteristics of the TUEF/TULIP cohort after stratification for the 6 clusters. P-values were computed with one-way ANOVA for continuous variables and two-sided chi-squared tests for categorical variables. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . hours of fasting for morning and >=5 hours of fasting after a light fat-free breakfast eaten before 8 am for afternoon OGTTs). Participants with prevalent or incident diabetes at baseline and those with non-white ethnicities were excluded. From the 6916 available baseline OGTTs, 6810 were complete cases in regards of the used clustering variables und underwent cluster assignments. The cohort characteristics are reported in Suppl. Table 12 . We aimed to identify subphenotypes that reflect differences in pathophysiological processes in the natural history of type 2 diabetes. The main paradigm of type 2 diabetes pathogenesis is an insufficient compensatory increase of insulin secretion in response to insulin resistance 31 . Therefore, insulin sensitivity and insulin secretion are key variables 6,7 . We used OGTT-based indices of insulin sensitivity (Matsuda-index) 32 and insulin secretion (AUC0-30 C-peptide/AUC0-30 glucose) that correlate well with gold-standard measures and are preferable to static measurements obtained in the fasting state 33,34 . Glycaemia was quantified in the partitioning procedure as AUC0-120 glucose. Furthermore, we aimed to capture diverse etiologies of insulin resistance by accounting for visceral and subcutaneous adipose tissue volume (VAT and SCAT), that have distinct metabolic characteristics 35 . We especially focused on elevated liver fat content, as it is strongly associated with insulin resistance 36 . HDL-cholesterol levels have been long known as explanatory variables of the metabolic syndrome and insulin resistance 37 . Moreover, causal inference from large genomic datasets provides evidence not only for a genetic correlation of HDL-cholesterol levels with type 2 diabetes, but also for a causal link between HDL-cholesterol levels and type 2 diabetes 9 . We also added a genome-wide polygenic risk score (PRS) to the analysis to better differentiate between genetically determined beta-cell dysfunction and environmentally determined beta-cell dysfunction. The correlation of the clustering variables is reported in Suppl. Table 13 . For computation of the PRS, we used the LDpred algorithm of Vilhjalmson et al. 38 on a combination of BMI-adjusted effect sizes and p-values from a meta-analysis in ~900.000 European individuals and genotypes 11 . After quality control, exclusion of multi-allelic and low-frequency variants, we combined 484.788 variants from the two . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . For assigning participants in the Whitehall II cohort to clusters established in TUEF/TULIP, we used proxy variables. Since liver fat, visceral adipose tissue and subcutaneous adipose tissue were not available in the Whitehall II cohort, and only two-point OGTTs were performed, other anthropometric variables and analytes were employed instead of these variables. Variables were selected based on statistical consideration (correlation) and pathophysiologic (theoretical) connection to the original trait (e.g. liver fat -fasting triglycerides, fasting insulin and waist circumference). Transaminase activity was not available during the early phases of the Whitehall II study. The final variable set was selected upon the highest agreement in re-identification of the original cluster assignments using the new proxy variables in TUEF. The variables used in Whitehall II comprised glycemia during glucose challenge, insulin sensitivity 32 , Stumvoll's first phase insulin secretion index using insulin and glucose levels at fasting and at 120 min during OGTT 39 , fasting insulin, fasting triglycerides, waist circumference, hip circumference, BMI and HDLcholesterol. The median values of these variables in TUEF/TULIP were used to assign participants to clusters in Whitehall II (Extended data 1) by taking the nearest neighbors of the 6 cluster-centers based upon Euclidean distances. Since Whitehall-II used a restricted CVD-focused genotyping platform with only 48000 markers and the release of full-scale genotyping data was not readily available, we decided to omit the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . genetic risk score from the re-assignment procedure. Despite these limitations, successful re-assignment of the clusters was achieved in 63% of the original TUEF cohort. All participants of TUEF/TULIP received a 75-g glucose solution (Accu-Check Dextro, Roche) at 8 a.m. following an overnight fast. Venous blood was obtained through an indwelling venous catheter before and 30, 60, 90 and 120 minutes after glucose ingestion. In the Whitehall II cohort, the OGTT procedure has been described earlier. In short, venous blood samples were collected after an overnight fast in the morning (≥8 hours of fasting) or in the afternoon after no more than a light fat-free breakfast eaten before 08.00 h (≥5 hours of fasting) followed by a standard 75g OGTT with a venous blood sample taken 2 hours after ingestion of the glucose solution. Glucose was analyzed in the Whitehall II study using an YSI glucose analyser (Yellow Springs Instruments). Glucose values were measured in TUEF/TULIP directly using a bedside glucose analyzer (YSI, Yellow Springs, CO or Biosen C-line, EKF-diagnostic, Barleben). In TUEF/TULIP, all other obtained blood samples were put on ice, the serum was centrifuged within 2 hours. Plasma insulin and C-peptide were determined by an immunoassay with the ADVIA Centaur XP Immunoassay System and HDL was measured using the ADVIA XPT clinical chemical analyser (all from Siemens Healthineers, Eschborn, Germany), while triglycerides were measured with standard colorimetric methods using a Bayer analyzer. In Whitehall II, insulin was measured with an in-house human insulin RIA and later with a DAKO ELISA kit (DAKO Cytomatin Ltd, Ely, UK). Serum creatinine was measured using a kinetic colorimetric (Jaffe) method on a Roche "P" Modular system (phase 9) and on a COBAS 8000 system (phase 11). Lipid measurements were described previously 40 . HbA1c measurements were performed using Tosoh glycohemoglobin analyzers in both studies (Tosoh Bioscience Tokyo Japan). Body fat distribution variables, i.e., VAT and SCAT, were determined by whole-body T1-weighted MRI as described earlier 41 . Liver fat content was measured by volume is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . 30 described previously 14 . The operator performing the segmentation (JM) was not aware of the cluster assignments. The procedure could not be completed in 6 participants (2% missing) due to breathing artefacts in the images. Renal sinus fat data for clusters 1 to 4 were partly available from segmentations for previous projects (mean data availability 40% over cluster 1 to 4). For detection of incident diabetes, either of the following was used: clinically ascertained diabetes (from patient history, or by the use of a diabetes-medication), an elevated fasting glucose (>=7 mmol/l), post-challenge glucose (>=11.1. mmol/l, or HbA1c (48 mmol/mol or 6.5%) in both cohorts. To assess the Ahlqvist-classification 6 for the subtypes of diabetes in Whitehall II, we used insulin-based HOMA2-indices, because C-peptide was not measured. GAD measurements were not available. HbA1c assessment had been introduced beginning with Phase 7. Cluster assignment was is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint incident CHD was defined as CHD death, nonfatal CHD and typical angina ascertained from clinical records, without self-reported cases from the Rose angina questionnaire. The cases were ascertained from participants' general practitioners, information extracted from hospital medical records by study nurses, or data from the NHS Hospital Episode Statistics (HES) and death register databases obtained after linking the participants' unique NHS identification numbers to this national database. Mortality data until June 2015 was drawn from the British National Mortality Register (National Health Service [NHS] Central Register) using each participants' NHS identification number. Statistical analyses were performed using R version 3.4.3 48 . In the clustering analysis, distances were computed as Gower-distances using standardized variables (scaled to a mean of 0 and SD of 1). Participants with outlier variables (absolute standardized levels >= 5) were excluded from the clustering procedure. To find the optimal cluster count, we evaluated the dendogram and silhouette-widths. The clustering procedure was performed with the partitioning around medoids (pam) method in the R-package "cluster", which is a more robust version of k-means clustering 49 . Using repeated subsetting with the clusterboot function from the fpc package, the mean Jaccardsimilarity measure was 0.74 across all clusters. 50 To further validate the stability of clusters, we iterated the clustering procedure for each of the 429 participants who had repeated measurements comprising all clustering variables (mean number of measurements 2.6±0.9, follow-up duration 4.2±3.6 years, also see Extended Data 8). We assessed the per-participant agreement of the generated 1112 cluster assignments using interrater reliabilities. The ICC2k value for cluster agreement was 0.72 (CI 0.68 -0.76). Detailed reports on means and SDs of the clustering variables in both cohorts and the cluster medians are provided in Suppl.Tables 14-15. Cluster means were compared using ANOVA. Specific outcomes were compared using ANCOVA adjusting for covariates such as sex, age and BMI. Post-hoc comparisons were performed using Tukey's honest significant differences procedure. Endpoints related to diabetes complications were analyzed in the follow-up data of both cohorts using survival analysis and proportional hazard models. Differences in cumulative risks for reaching endpoints were tested with log-rank tests. When not . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint 32 indicated otherwise, the uncorrected p-value of a specific cluster's risk relative to cluster 1 is provided in the proportional hazard analysis. Given the relatively low number of outcomes in TUEF/TULIP (40 for diabetes and 71 for microalbuminuria), assessment of proportional hazards adjusted for potential confounders was performed in the Whitehall II cohort only. Proportional hazards assumptions were tested by visualization of the Schoenfeld-residuals. The performed statistical tests were twosided. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. The R code used to generate all results of this manuscript is available upon request. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 14, 2020. 1320 1224 1070 879 607 0 4148 3930 3454 2949 2147 0 311 271 199 129 69 0 489 464 394 323 233 0 121 101 63 31 18 0 254 233 176 121 73 0 cluster=6 cluster=5 cluster=4 cluster=3 cluster=2 cluster=1 No. at risk 0 18 54 126 195 215 0 28 73 150 264 283 0 17 55 95 116 122 0 4 16 36 59 64 0 15 39 64 69 71 0 5 23 57 71 Prediabetes: a high-risk state for diabetes development Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes Non-alcoholic fatty liver disease and impaired proinsulin Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome Causes and metabolic consequences of Fatty liver The metabolic syndrome Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study Standardized assessment of whole body adipose tissue topography by MRI Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial Hofman Albert & Grobbee Diederick E. Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction Mannheim Carotid Intima-Media Thickness and Plaque Consensus A New Equation to Estimate Glomerular Filtration Rate Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Job insecurity and incident coronary heart disease: the Whitehall II prospective cohort study R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing Clustering Rules: A Comparison of Partitioning and Hierarchical Clustering Algorithms Cluster-wise assessment of cluster stability 1004 990 953 893 586 3306 3240 3061 2831 1865 227 211 193 174 105 365 357 336 307 207 86 82 72 63 37 194 184 165 153 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.12.20210062 doi: medRxiv preprint